WEE1 and glioblastoma: The primary focus of studies on differentiation therapy for GBM centres around the induction of differentiation into astrocytes or neurons, typically accomplished through the utilisation of chemical inducers, protein kinase inhibitors, transcription factors or miRNA transgenes [12, 13, 15, 31, 32].